Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Neurochem Int. 2016 Jun 14;99:72–84. doi: 10.1016/j.neuint.2016.06.009

Table 2.

Metabolites in Physiological Fluids from Patients with SSADHD

Metabolite Urine (mmol/mol creatinine) Plasma (μM) Cerebrospinal fluid (μM)
GHB 34-514 (n=10)
(nl < 10)
26-533 (n=17)
(nl < 3)
116-1110 (n=4)
(nl < 3)
D-2-HG 22-102 (n=7)
(nl < 18)
3.1-7.6 (n=4)
(nl < 1)
0.4-4.7 (n=6)
(nl < 0.3)
SSA 3-20 (n=13)
(nl < 2)
-- 1280-2570 (n=3; nmol/L)
(nl < 10)
DHHA -- -- --
GABA ND -- 13.6-22.4 (n=4; total GABA)
(nl < 12)
Homocarnosine -- -- 14.8-41 (n=9)
(nl < 10)
GBA 4.6-35 (n=7)
(nl < 5.8)
-- 0.04-0.32
(nl < 0.03)

Legend: Abbreviations: GHB, γ-hydroxybutyric acid; D-2-HG, D-2-hydroxyglutaric acid; SSA, succinic semialdehyde; DHHA, 4,5-dihydroxyhexanoic acid; GABA, γ-aminobutyric acid; GBA, guanidinobutyrate; nl,normal; ND, not done. SSA in cerebrospinal fluid is reported in units of nmol/L. Total GABA refers to free and esterified forms of GABA (including esterified forms such as homocarnosine). See Fig. 2 for metabolic interconversions.